Triglycerides induce leptin resistance at the blood-brain barrier.
Obesity is associated with leptin resistance as evidenced by hyperleptinemia. Resistance arises from impaired leptin transport across the blood-brain barrier (BBB), defects in leptin receptor signaling, and blockades in downstream neuronal circuitries. The mediator of this resistance is unknown. Here, we show that milk, for which fats are 98% triglycerides, immediately inhibited leptin transport as assessed with in vivo, in vitro, and in situ models of the BBB. Fat-free milk and intralipid, a source of vegetable triglycerides, were without effect. Both starvation and diet-induced obesity elevated triglycerides and decreased the transport of leptin across the BBB, whereas short-term fasting decreased triglycerides and increased transport. Three of four triglycerides tested intravenously inhibited transport of leptin across the BBB, but their free fatty acid constituents were without effect. Treatment with gemfibrozil, a drug that specifically reduces triglyceride levels, reversed both hypertriglyceridemia and impaired leptin transport. We conclude that triglycerides are an important cause of leptin resistance as mediated by impaired transport across the BBB and suggest that triglyceride-mediated leptin resistance may have evolved as an anti-anorectic mechanism during starvation. Decreasing triglycerides may potentiate the anorectic effect of leptin by enhancing leptin transport across the BBB.
Banks
William A
WA
Department of Internal Medicine, Division of Geriatrics, Geriatric Research, Education, and Clinical Center, Veterans Affairs Medical Center, St. Louis University School of Medicine, 915 N. Grand Boulevard, St. Louis, MO 631056, USA. bankswa@slu.edu
Coon
Alan B
AB
Robinson
Sandra M
SM
Moinuddin
Asif
A
Shultz
Jessica M
JM
Nakaoke
Ryota
R
Morley
John E
JE
D000818:Animals; D001692:Biological Transport / Q000187:drug effects; D001812:Blood-Brain Barrier / Q000187:drug effects* / Q000502:physiology*; D004351:Drug Resistance; D005217:Fat Emulsions, Intravenous / Q000494:pharmacology; D015248:Gemfibrozil / Q000494:pharmacology; D015228:Hypertriglyceridemia / Q000097:blood; D000960:Hypolipidemic Agents / Q000494:pharmacology; D020738:Leptin / Q000378:metabolism / Q000502:physiology*; D008297:Male; D051379:Mice; D008815:Mice, Inbred Strains; D008892:Milk; D014280:Triglycerides / Q000037:antagonists & inhibitors / Q000097:blood / Q000494:pharmacology*
D005217:Fat Emulsions, Intravenous; D000960:Hypolipidemic Agents; D020738:Leptin; D014280:Triglycerides; D015248:Gemfibrozil